Critical Review: Surgery Partners (SGRY) & Its Peers

Surgery Partners (NASDAQ: SGRY) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it weigh in compared to its competitors? We will compare Surgery Partners to similar businesses based on the strength of its dividends, risk, valuation, profitability, earnings, institutional ownership and analyst recommendations.

Risk & Volatility

Surgery Partners has a beta of 1.89, indicating that its stock price is 89% more volatile than the S&P 500. Comparatively, Surgery Partners’ competitors have a beta of 1.47, indicating that their average stock price is 47% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Surgery Partners and its competitors, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgery Partners 1 3 4 0 2.38
Surgery Partners Competitors 57 326 509 9 2.52

Surgery Partners presently has a consensus price target of $18.00, suggesting a potential upside of 115.57%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 22.25%. Given Surgery Partners’ higher possible upside, equities analysts plainly believe Surgery Partners is more favorable than its competitors.

Valuation & Earnings

This table compares Surgery Partners and its competitors revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Surgery Partners $1.15 billion $9.45 million -18.15
Surgery Partners Competitors $1.06 billion -$22.56 million 738.92

Surgery Partners has higher revenue and earnings than its competitors. Surgery Partners is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Surgery Partners and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Surgery Partners -0.33% 1.03% 0.20%
Surgery Partners Competitors 3.52% 3.52% 4.31%

Institutional and Insider Ownership

94.2% of Surgery Partners shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by company insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Surgery Partners competitors beat Surgery Partners on 8 of the 13 factors compared.

Surgery Partners Company Profile

Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.

What are top analysts saying about Surgery Partners Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Surgery Partners Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit